# Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled Trial

> **NCT06362291** · NA · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 380 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** MRI-AI guided cognitive prostate targeted biopsy
- **PROCEDURE:** Routine cognitive prostate targeted biopsy

## Key facts

- **NCT ID:** NCT06362291
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-01
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 380 (ACTUAL)
- **Last updated:** 2024-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06362291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06362291, "Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06362291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*